Sinphar Pharmaceutical Co Ltd (1734) — Working Capital to Net Assets Ratio
Sinphar Pharmaceutical Co Ltd (1734) has a Working Capital to Net Assets ratio of 41.9% as of March 2026. Working capital of NT$1.59 Billion (current assets of NT$2.76 Billion minus current liabilities of NT$1.16 Billion) is measured against net assets of NT$3.81 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Sinphar Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sinphar Pharmaceutical Co Ltd Working Capital to Net Assets (2004–2025)
This chart shows how Sinphar Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 41.9%, reflecting working capital of NT$1.59 Billion against net assets of NT$3.81 Billion TWD. See 1734 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Sinphar Pharmaceutical Co Ltd (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sinphar Pharmaceutical Co Ltd from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Sinphar Pharmaceutical Co Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 40.9% | NT$1.52 Billion | NT$3.72 Billion | NT$2.53 Billion | NT$1.01 Billion | ▲ +7.0 pp |
| 2024 | 33.9% | NT$1.20 Billion | NT$3.55 Billion | NT$2.62 Billion | NT$1.42 Billion | ▼ -8.6 pp |
| 2023 | 42.5% | NT$1.44 Billion | NT$3.40 Billion | NT$2.65 Billion | NT$1.20 Billion | ▲ +1.1 pp |
| 2022 | 41.4% | NT$1.33 Billion | NT$3.22 Billion | NT$2.78 Billion | NT$1.45 Billion | ▲ +3.4 pp |
| 2021 | 38.0% | NT$1.17 Billion | NT$3.08 Billion | NT$2.70 Billion | NT$1.53 Billion | ▼ -0.5 pp |
| 2020 | 38.5% | NT$1.21 Billion | NT$3.14 Billion | NT$2.54 Billion | NT$1.33 Billion | ▲ +3.9 pp |
| 2019 | 34.5% | NT$1.11 Billion | NT$3.20 Billion | NT$2.26 Billion | NT$1.16 Billion | ▼ -1.5 pp |
| 2018 | 36.0% | NT$1.23 Billion | NT$3.42 Billion | NT$2.12 Billion | NT$889.30 Million | ▼ -2.8 pp |
| 2017 | 38.8% | NT$1.41 Billion | NT$3.63 Billion | NT$2.26 Billion | NT$851.35 Million | ▲ +1.0 pp |
| 2016 | 37.8% | NT$1.43 Billion | NT$3.78 Billion | NT$2.36 Billion | NT$933.55 Million | ▲ +5.0 pp |
| 2015 | 32.8% | NT$1.30 Billion | NT$3.96 Billion | NT$2.32 Billion | NT$1.02 Billion | ▼ -7.7 pp |
| 2014 | 40.5% | NT$1.65 Billion | NT$4.08 Billion | NT$2.79 Billion | NT$1.13 Billion | ▲ +11.5 pp |
| 2013 | 29.0% | NT$1.01 Billion | NT$3.49 Billion | NT$2.23 Billion | NT$1.22 Billion | ▼ -4.3 pp |
| 2012 | 33.3% | NT$896.45 Million | NT$2.69 Billion | NT$1.63 Billion | NT$734.15 Million | ▲ +4.7 pp |
| 2011 | 28.6% | NT$760.85 Million | NT$2.66 Billion | NT$1.86 Billion | NT$1.10 Billion | ▼ -2.5 pp |
| 2010 | 31.1% | NT$672.89 Million | NT$2.16 Billion | NT$1.30 Billion | NT$629.78 Million | ▲ +3.5 pp |
| 2009 | 27.6% | NT$578.26 Million | NT$2.09 Billion | NT$1.34 Billion | NT$757.04 Million | ▲ +14.5 pp |
| 2008 | 13.1% | NT$232.07 Million | NT$1.77 Billion | NT$1.35 Billion | NT$1.12 Billion | ▼ -6.3 pp |
| 2007 | 19.4% | NT$329.46 Million | NT$1.70 Billion | NT$1.23 Billion | NT$899.67 Million | ▲ +2.1 pp |
| 2006 | 17.3% | NT$287.47 Million | NT$1.66 Billion | NT$1.17 Billion | NT$882.12 Million | ▼ -9.6 pp |
| 2005 | 26.9% | NT$442.09 Million | NT$1.64 Billion | NT$1.39 Billion | NT$949.48 Million | ▲ +9.6 pp |
| 2004 | 17.3% | NT$227.13 Million | NT$1.32 Billion | NT$1.06 Billion | NT$837.52 Million | — |